Letter: serum growth differentiation factor 15 predicts hepatocellular carcinoma occurrence after hepatitis C virus elimination

Aliment Pharmacol Ther. 2022 Apr;55(8):1059-1060. doi: 10.1111/apt.16834.

Authors

Lin Chen¹, Xuemei Tao¹, Youfei Zhao¹, Minghui Zeng¹, Yuqiang Mi^{1

2

3}, Liang Xu^{1

2}

Affiliations

¹ Clinical School of the Second People's Hospital, Tianjin Medical University, Tianjin, China.
² Department of Hepatology, Tianjin Second People's Hospital, Tianjin, China.
³ Tianjin Research Institute of Liver Diseases, Tianjin, China.

PMID: 35362130
DOI: 10.1111/apt.16834

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Carcinoma, Hepatocellular* / diagnosis
Growth Differentiation Factor 15* / blood
Hepacivirus
Hepatitis C* / complications
Humans
Liver Neoplasms* / diagnosis

Substances

GDF15 protein, human
Growth Differentiation Factor 15